Assessment of canine vocal fold function after injection of a new biomaterial designed to treat phonatory mucosal scarring.

Objectives: Most cases of irresolvable hoarseness are due to deficiencies in the pliability and volume of the superficial lamina propria of the phonatory mucosa. By using a US Food and Drug Administration-approved polymer, polyethylene glycol (PEG), we created a novel hydrogel (PEG30) and investigated its effects on multiple vocal fold structural and functional parameters.

Methods: We injected PEG30 unilaterally into 16 normal canine vocal folds with survival times of 1 to 4 months.